Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ya I am pretty sure tire kicking has been going on since the first news hit of license being possibly revoked. I held my shares all this time for 2 reasons
#1 ASNT retains license and continues with planned operations.
#2 ASNT is acquired by a larger company that will put all the facilities and equipment to use asap.
JMHO
As mentioned earlier we might become a takeover target if HC rules against and this opens the door to expedite the process in my view as it's not only a huge block of shares but also controlling share block
Health Canada ruling can go either way, and I wouldn't be surprised if there isn't already some tire kicking going on
That's some news I didn't expect, I will have to do some DD on Malcom. Maybe we can try fig out what his plans might be..
Ascent (PGTMF CNSX.ASNT) shareholder Malcolm acquires 116.75 M shares
2019-02-04 10:29 ET - News Release
Mr. Drew Malcolm, a shareholder, reports
EARLY WARNING NEWS RELEASE
Drew Malcolm, a shareholder of Ascent Industries Corp., has provided the following update in accordance with National Instrument 62-103, The Early Warning System and Related Take Over Bids, and National Instrument 62-104, Take-Over Bids and Issuer Bids.
Mr. Malcolm advises that, on Feb. 1, 2019, he acquired control or direction over 116,756,421 common shares in the capital of the issuer, pursuant to certain voting trust agreements under which Mr. Malcolm has been appointed as the voting trustee.
On Feb. 1, 2019, Terry Booth, Donald Campbell, Hope Rudl, Mark Parr, James Fitzpatrick, Reid Parr, Philip Campbell, James Poelzer, Quintet Ventures Inc. and Lola Ventures Inc. (the concerned shareholders) each entered into separate voting trust agreements with Mr. Malcolm. Each voting trust agreement grants Mr. Malcolm complete discretion and control in exercising the voting rights related to all shares that are beneficially owned by each of the concerned shareholders. As a result of the voting trust agreements, Mr. Malcolm acquired voting control or direction over 116,756,421 shares.
Immediately before the completion of the acquisition, Mr. Malcolm beneficially owned or controlled 24,104,086 shares, representing approximately 7.66 per cent of the then issued and outstanding shares. As a result of the acquisition, Mr. Malcolm beneficially owns or controls 140,860,507 shares, representing approximately 44.78 per cent of the currently issued and outstanding shares (46.45 per cent on a partially diluted basis).
Mr. Malcolm acquired voting control over the shares to more effectively exercise the rights of the concerned shareholders with a view of obtaining more fulsome disclosure regarding the issuer's future business plans. Mr. Malcolm and the concerned shareholders hold the shares for investment purposes and will review their holdings from time to time and may, in the future, increase or decrease their ownership or control over securities of the issuer as circumstances dictate in accordance with the terms of the voting trust agreements.
An early warning report will be filed under the issuer's profile on SEDAR. A copy of the early warning report can also be obtained from Mr. Malcolm at 778-819 6451.
The issuer's head office is located at Suite 260, 22529 Lougheed Highway, Maple Ridge, B.C., V2X 0T5.
© 2019 Canjex Publishing Ltd. All rights reserved.
It is about time for some good news from management on license. Hopefully we hear something soon.
New companies that are from outside the USA go Grey for about a 1/2 year to 1 year I have found with other tickers over the years. Once they have a steady pattern of being up to date on filings/fin then OTC changes to current
Likely business, as usual, it will come together:)
We should be hearing something pretty soon I imagine about the license. Considering Canada is predicting MJ shortages for 2-3 years HC would have to be crazy to permanently revoke the cultivation license. IMO
Ascent trades on the Canadian Stock Exchange CNSX:ASNT...... There is another ticker which you referred to accommodate foreign investors outside of Canada. This is a common practice between countries.
When the ticker is upgraded you will not be able to purchase shares at this current pps. You can buy now like many others have or wait and pay more.
CNSX:ASNT or OTC:PGTMF
I live in Canada, know their products and some of their facilities are across the river from me. Hope this was helpful to you:)
.
This company is trading on the OTC grey market. I can't seem to find any information as to why it's not on the regular OTC. I wanted to start accumulating but this gives me pause. Has this been addressed somewhere that I can read up on? I saw the reference at the top of the page that they were going to start trading on OTC but it doesn't address why it's on the greys. Has that process been completed? It seems like it would be better to buy the Canadian version but I'm reluctant to spend the extra money in commissions if I don't have to.
Thanks...
"The Refinancing consolidates both the Mortgage and Convertible...... Note into one secured loan,... https://ascentindustries.com/press-releases/2018/ascent-industries-announces-debt-refinancing-and-working-capital-loan/
Sounds like a positive move lining up a better loan structure and thinking about the future.
ASCENT INDUSTRIES ANNOUNCES DEBT REFINANCING AND WORKING CAPITAL LOAN
Vancouver, B.C. – Ascent Industries Corp. (CSE: ASNT) (“Ascent” or the “Company“) is pleased to announce that it has completed a refinancing of its two senior secured debt facilities (the “Refinancing”), and has obtained working capital for its business, through a private international lender. Under the Refinancing, the Company has replaced both the $1.7 million first mortgage attached to its Maple Ridge property in Canada (the “Mortgage”), and the $4 million convertible note in respect of the Company’s Las Vegas, Nevada, property (the “Convertible Note”), with a single loan secured against the Maple Ridge and Nevada properties that includes working capital of approximately $1 million. In connection with the Refinancing, the Company issued 150,000 warrants to one of the holders of the Convertible Note, each warrant allowing the holder to purchase one common share of Ascent at a price of $0.30 per share, until January 4, 2021.
The Refinancing consolidates both the Mortgage and Convertible Note into one secured loan, which with the working capital portion totals $7 million, bearing interest at a rate of 10% per annum and due on July 15, 2019 or such later date as agreed between the Company and the lender. The Refinancing also eliminates the conversion feature attached to the Convertible Note pursuant to which the Company would have been required to issue over 11 million shares at the strike price of $0.35 per share if converted.
About Ascent Industries Corp.
The Company’s operations currently include facilities in British Columbia, Canada; and in Oregon and Nevada in the United States. In Canada, Ascent (through its wholly-owned subsidiary, Agrima) is a licensed producer (currently suspended) under the Cannabis Act and Regulations, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a licensed dealer (currently suspended) under the Cannabis Act and Cannabis Regulations, with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licensed entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program.
The Canadian Securities Exchange (the “CSE”) has neither approved nor disapproved the contents of this press release. NEITHER THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to Ascent’s expectations on the reinstatement of the Licences. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the risk that the hearing will not be successful, and Health Canada will revoke the Licences or continue the Suspension for an indefinite period of time; the Company may be subject to sanctions (monetary or otherwise), litigation risk and other regulatory and legislative risk; and general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Ascent assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
For further information:
Blair Jordan – Interim CEO
+1 604-928-2988
ir@ascentindustries.com
Still loading, we know how intelligent you are
Thanks WSK, that's fairly soon! Business as usual:)
So what's you calculated guesstimate WallStreetKid?
It took six weeks last time and that was Dec 3rd, I imagine the holidays probably will add another 2 weeks
Anyone hear any news on the HC license situation? I have a pretty good feeling that with the change in management ASNT will have no problems retaining their cultivation license. IMO
GO ASNT $$
Yessssssssss definitely!!!
Mid-January for Ascent?
Likely a big winner 2019, holding onto CNSX:ASNT:)
Nice GREEN Close for ASNT
I agree, most likely license is kept by company. If not some othe licensed MJ company will aquire it and then we just own stocks in that...
Most don't buy on uncertainty and even fewer roll the dice on bad news. They will be bought out if not relicensed put it in a newsletter that it is a viable option for and I'm sure it's already in the works as they even maximising shareholder value
I wouldn't be surprised if there are talks going on
$6,500 dollars-worth traded on its' U.S. exchange PGTMF
That's like what maybe 3 guys who're participating
Or 6 because where there's a buyer there's a seller
Shouldn't volume figures trigger a red flag ?
And WHY would it be so low ?....I dunno.
What might the market capitalization be ?
How many shares OS ?
Anyone know ?
$6,500 dollars-worth traded on its' U.S. exchange
That's like what maybe 3 guys who're participating
Or 6 because where there's a buyer there's a seller
Shouldn't volume figures trigger a red flag ?
And WHY would it be so low ?....I dunno.
What might the market capitalization be ?
How many shares OS ?
Anyone know ?
I'm thinking new buyers, last few weeks been 800-1.1 I think it's more than one buyer one is a bid sitter and the other a slapper. Just my feeling but feel today was a high volume tug of war. I wasn't following the action and just notice the volume spike
What was the other ticker like today?
Just did the math though = Only $ 57,000 bucks worth (at .18) ?
And yet yer sayin' that volume was close to triple the normal ?
Yikes ; Sure enuf eh A Giant Green Bar (albeit preceeded by a red)
Anyways,
Man....Company should be named "Descent" not "Ascent" . . . .
I like 'em tho (I think), don't get me wrong....
There's nice soil in Pitt Meadows
Plus cheap labour there !
Just learned I can insert I-Hub charts !
But wish I could acsess 10 day 1-minuters
Volume before price today was close to triple volume
CNSX:ASNT Nice moves today:)
I'm not worried about it, buying more at these prices. When they get the HC Approval, then the ticker upgrade this little hidden gem should move up significantly:)
It's trying, many on the fence doing a wait & see approach regarding the HC issue
CNSX:ASNT Ascent wanting to stretch its legs
ASNT~"AURORA CANNABIS SIGNS SUPPLY AGREEMENT WITH ASCENT INDUSTRIES"...
Ascent to supply up to 20,000 kg of dried cannabis flower and up to 6,000 kg of cannabis trim per year
NYSE: ACB
EDMONTON, June 11, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has signed a cannabis flower and trim supply agreement (the "Agreement") with Ascent Industries Corp's ("Ascent") wholly-owned subsidiary, Agrima Botanicals Corp. ("Agrima"), a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR").
Under the terms of the Agreement, Agrima will supply Aurora with up to 20,000 kg of dried cannabis flower and up to 6,000 kg of cannabis trim per year from its Canadian cultivation facilities. The Agreement is effective for a term of five years, subject to a 12,000 kg per year minimum.
"The agreement with Ascent brings further differentiation to Aurora's growing portfolio of products," said Terry Booth, CEO. "Expanding product choice to our various audiences through quality operators such as Agrima positions us well to accelerate growth. Furthermore, the relationship provides an opportunity to potentially source additional, higher-margin derivative products down the line."
Philip Campbell, CEO and Director of Ascent added, "We are delighted to be selected as a supplier to Aurora, a leader in the global cannabis sector. Agrima is committed to providing high-quality cannabis to both consumers and strategic partners, which this new agreement is testament to. We believe this represents the beginning of a strong strategic relationship with Aurora, one which will benefit both companies for years to come."
Ascent's wholly-owned subsidiary, Agrima will supply Aurora with dried cannabis flower and trim grown at its facilities in Pitt Meadows, British Columbia. Once operational, the 600,000 square foot, automated cultivation facility will have a total cultivation capacity of approximately 60,000 kg of cut flower per year. Agrima anticipates receiving Health Canada approval towards the end of calendar 2018, and anticipates shipping its first products in Q1 2019.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as "Aurora Mountain", and a second 40,000 square foot high-technology production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island. In January 2018, Aurora's 800,000 square foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed by Health Canada. Once at full capacity, Aurora Sky is expected to produce over 100,000 kg per annum of cannabis. Aurora is completing a facility in Lachute, Quebec utilizing its wholly owned subsidiary Aurora Larssen Projects Inc. ("ALPS"). ALPS provides comprehensive project services related to the design, engineering, construction support, compliance requirement, genetics, commissioning and maintenance of Aurora Standard production facilities across the globe.
The Company's wholly-owned subsidiary CanniMed Therapeutics Inc. ("CanniMed") is Canada's first licensed producer of medical cannabis, with over 20,000 kg per annum in funded capacity. Aurora also owns Berlin-based Pedanios GmbH, the leading wholesale importer, exporter, and distributor of medical cannabis in the European Union. The Company owns 51% of Aurora Nordic, which will be constructing a 1,000,000 square foot hybrid greenhouse in Odense, Denmark.
The Company offers further differentiation through its acquisition of BC Northern Lights Ltd. and Urban Cultivator Inc., industry leaders, respectively, in the production and sale of proprietary systems for the safe, efficient and high-yield indoor cultivation of cannabis, and in state-of-the-art indoor gardening appliances for the cultivation of organic microgreens, vegetables and herbs in home and professional kitchens.
Aurora holds a 25% ownership interest in Alcanna Inc. ("CLIQ"), Western Canada's largest private retail chain of liquor stores, who are developing a cannabis retail network in Western Canada. In addition, the Company holds approximately 17% of the issued shares in leading extraction technology company Radient Technologies Inc, and holds 52.7% of Hempco Food and Fiber Inc.
Aurora is also the cornerstone investor in two other licensed producers, with a 22.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis, and a 17.62% stake in Canadian licensed producer The Green Organic Dutchman Ltd., with options to increase to majority ownership. Finally, the Company owns a 9.14% stake in CTT Pharmaceutical, an innovative product development company within the cannabis space.
Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.
About Ascent
In Canada, Ascent is a Licensed Producer under the ACMPR of Health Canada, with licenses to cultivate cannabis and produce cannabis extracts. In addition, the Company plans to apply for a license to distribute cannabis products in Canada under the ACMPR in the near future. The Company has also applied for a controlled drugs license in Canada under the Controlled Drugs and Substances Act (Canada). In the United States, the Company holds licenses for the production, processing and wholesale distribution of cannabis in Oregon and in Nevada.
The Company's operations currently include licensed facilities in British Columbia, Canada, and in Oregon and Nevada in the United States. The Company's activities at each facility are governed by the applicable licenses held by the Company, and currently include cultivation and extraction in Canada, and production, processing and wholesale distribution of a catalogue of premium cannabis products in Oregon and Nevada. In addition, Ascent conducts cannabis-based research with Simon Fraser University and the University of Kentucky.
The Company is increasing its production capacity from 50,000 square feet to 650,000 square feet in 2018, from which it expects to produce significantly larger quantities of cannabis and cannabis oil to support its expanding operations. The Company offers a product suite of more than 40 unique products under eight consumer focused brands, including gel capsules, oils, vaporizer pens, pre-rolled joints, various edibles and raw flower. Through careful development of its sophisticated cannabis brands, Ascent is positioned to be a leader in branded, commercialized products in both medical and adult-use markets across North America and internationally. The Company's intellectual property portfolio includes existing trademarks for its sophisticated brands, applications for trademarks internationally for these brands, as well as applications for patents the Company has and is in the process of filing for certain unique scientific formulations and processes the Company has created.
Forward looking statements
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
Terry Booth, CEO
Aurora Cannabis Inc.
SOURCE Aurora Cannabis Inc. https://investor.auror
Or buy more cheapies
Yes indeed, we missed you last night :(
Nice day, good to see the GREEN:)
Thanx for trying
Fidelity is overpriced, switch to Eturd or TdAmurica
It may still show up as Padget on some sites but is indeed us
Yes it is & welcome aboard
What about the US Ticker, it still gives people a slight idea but they have to keep in mind the price differential due to the exchange rate between ASNT.CSX & $PGTMF
This facility's across the river from me:) https://vimeo.com/277159090
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
568
|
Created
|
08/10/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |